あすか製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証1部 | 医薬品 | 4514/E00929 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2020/10/09 | 日証協 | 149,377株 | +59.66% | 141,700株 | +32.31% | 210,661株 | +30.89% | 99,810株 | -13.96% |
2020/10/02 | 日証協 | 93,561株 | -20.62% | 107,100株 | +99.81% | 160,942株 | -4.43% | 116,002株 | +78.15% |
2020/09/25 | 日証協 | 117,861株 | -66.96% | 53,600株 | +85.47% | 168,405株 | -50.7% | 65,116株 | +1.11% |
2020/09/18 | 日証協 | 356,761株 | -2.91% | 28,900株 | -72.05% | 341,589株 | -7.25% | 64,400株 | -75.63% |
2020/09/11 | 日証協 | 367,461株 | +11.23% | 103,400株 | +265.37% | 368,289株 | +157.55% | 264,300株 | +1728.94% |
2020/09/04 | 日証協 | 330,361株 | +0.92% | 28,300株 | +4.9% | 142,999株 | +8.13% | 14,451株 | -91.33% |
2020/08/28 | 日証協 | 327,341株 | -30.49% | 26,978株 | +180.47% | 132,248株 | -8.26% | 166,700株 | +836.52% |
2020/08/21 | 日証協 | 470,932株 | -1.77% | 9,619株 | +35.48% | 144,148株 | -4.63% | 17,800株 | +30.88% |
2020/08/14 | 日証協 | 479,432株 | -0.52% | 7,100株 | -63.4% | 151,148株 | +0.87% | 13,600株 | +183.33% |
2020/08/07 | 日証協 | 481,932株 | -5.36% | 19,400株 | -17.45% | 149,848株 | -21.69% | 4,800株 | -31.91% |
2020/07/22 | 日証協 | 515,032株 | -2.39% | 12,700株 | -76.22% | 209,292株 | -5.04% | 1,906株 | -90.88% |
2020/07/17 | 日証協 | 527,632株 | -0.38% | 53,400株 | +30.24% | 220,392株 | +6.71% | 20,900株 | -0.76% |
2020/07/10 | 日証協 | 529,632株 | +4.03% | 41,000株 | +74.47% | 206,542株 | +7.84% | 21,060株 | -26.11% |
2020/07/03 | 日証協 | 509,113株 | -1.47% | 23,500株 | -62.45% | 191,532株 | +3.23% | 28,500株 | -48.56% |
2020/06/26 | 日証協 | 516,722株 | +3.99% | 62,588株 | +417.26% | 185,532株 | +9.86% | 55,400株 | +266.28% |
2020/06/12 | 日証協 | 495,666株 | -4.69% | 7,700株 | -65.16% | 168,440株 | -5.72% | 29,200株 | +76.03% |
2020/06/05 | 日証協 | 520,066株 | -0.29% | 22,100株 | -49.84% | 178,660株 | -10.65% | 16,588株 | +20.2% |
2020/05/29 | 日証協 | 521,562株 | -0.47% | 44,060株 | -9.22% | 199,960株 | -2.58% | 13,800株 | -45.45% |
2020/05/22 | 日証協 | 524,035株 | -7.57% | 48,533株 | -55.55% | 205,260株 | -13.16% | 25,300株 | -26.45% |
※株式分割は考慮していませんのでご注意ください。
Page Top